India pivots from generics to biologics with Biopharma Shakti, a major Budget 2026 push to expand R&D, clinical trials and access to life-saving drugs.
Go to Source
Author: News18
Go to Source
Author: News18
Hot this week
Free News - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Get important news delivered directly to your inbox and stay connected!
